Hoth Therapeutics Inc. (HOTH)
0.94
-0.04 (-3.92%)
At close: Apr 03, 2025, 3:59 PM
0.92
-1.66%
After-hours: Apr 03, 2025, 04:56 PM EDT
-3.92% (1D)
| Bid | 0.92 |
| Market Cap | 12.3M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -0.74 |
| Forward PE | -1.33 |
| Analyst | Buy |
| Ask | 0.93 |
| Volume | 365,333 |
| Avg. Volume (20D) | 9,164,238 |
| Open | 0.96 |
| Previous Close | 0.98 |
| Day's Range | 0.92 - 0.95 |
| 52-Week Range | 0.58 - 3.80 |
| Beta | 0.85 |
About HOTH
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 15, 2019
Employees 2
Stock Exchange NASDAQ
Ticker Symbol HOTH
Website https://www.hoththerapeutics.com
Analyst Forecast
According to 4 analyst ratings, the average rating for HOTH stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 381.03% from the latest price.
Stock Forecasts2 months ago
+178.18%
Hoth Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+1.05%
Hoth Therapeutics shares are trading higher after the company announced its board has approved the purchase of up to $1 million in Bitcoin.
